Targeting lymphangiogenesis to prevent tumour metastasis
about
The role of lymphatics in cancer as assessed by near-infrared fluorescence imagingThe role of lymphangiogenesis and angiogenesis in tumor metastasisCrosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironmentDynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Tumour vascularization: sprouting angiogenesis and beyondThe endogenous soluble VEGF receptor-2 isoform suppresses lymph node metastasis in a mouse immunocompetent mammary cancer model.Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects.Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathwayClinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic diseaseCryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathwaysThe contribution of B cells to renal interstitial inflammationVascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomasTumor lymphangiogenesis as a potential therapeutic target.Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteinsDesign, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK-VEGFR3 protein-protein interaction.Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors.Metastasis: recent discoveries and novel treatment strategies.Molecular targeting of liposomal nanoparticles to tumor microenvironment.The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.Vascular endothelial growth factor receptor-3 promotes breast cancer cell proliferation, motility and survival in vitro and tumor formation in vivo.Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryosCorrelation of vascular endothelial growth factor-D expression and VEGFR-3-positive vessel density with lymph node metastasis in gastric carcinoma.The clinical significance of lymphangiogenesis in renal cell carcinomaCirculating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy.The VEGF signaling pathway in cancer: the road ahead.The Role of the Tumor Vasculature in the Host Immune Response: Implications for Therapeutic Strategies Targeting the Tumor Microenvironment.Gene expression profile of lymphatic endothelial cells.Lymphatic vessels in health and disease.Mammary cancer gene therapy targeting lymphangiogenesis: VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant.Vascular remodeling in cancer.Lymphangiogenesis and lymphatic vessel remodelling in cancer.Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer.Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma.JAM-C promotes lymphangiogenesis and nodal metastasis in non-small cell lung cancer.Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.A novel pyrrolo[3, 2-d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet-derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis.Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.Lymphangiogenesis and colorectal cancer.
P2860
Q27001155-A86A815A-8B01-4F61-A590-8C7E1356904DQ28067309-B5C938BE-183E-4B81-9E0A-A70D4407BA9AQ28081431-FF9AC408-9B2D-4AE8-9AF4-E0C9CDC38720Q30482388-64051F26-F360-4662-B552-2F4BE6A8AA9BQ33555154-15F2191F-0085-46DF-B55A-085E4A75D59CQ33556162-7971A7F4-8F2B-47FC-B81E-1501BC1E2980Q33737146-53E5733D-47F9-44EF-8AD6-6C211C0993B8Q33977081-AD9702E3-131D-4F10-94C8-B2997A2A099FQ34003819-E706D9BB-A827-4FA9-9550-B53B6E8058F6Q34091198-03430356-DDBB-4E7C-9DAE-54ADEEA28EE2Q35597013-B2B7C198-5AA2-4702-BB64-A64DC44BC2D6Q35750182-8164E549-DEB8-46D9-9C18-BBB01E5A1BFFQ35836386-F0B792D0-FD76-479C-9B39-80F58AA484B2Q35838122-D723F432-4069-4FE0-A071-977FDA47A2B3Q35924859-88AED7FF-CE02-45BF-8299-AD99391D2959Q36051470-73D8FC2A-CC5D-4637-83CA-D5B264BEC5BCQ36198192-D3935480-D20C-4DA3-AA4D-1DF1D4B1F7F9Q36407511-A50C6FCC-629B-4512-9249-235D81024F50Q36500108-0A00E129-D00D-4DE6-AA46-2DEC8FDD2AD5Q36708521-57AFF508-F6C2-4224-85A5-12E337DAC1A2Q36749531-772BE33E-4D11-4741-B3AD-5922A0FADB3EQ36804671-65A4B6B5-AAD3-4239-A3B1-D3AAAFF56397Q36854026-CA8C32B5-A44C-435A-8AA5-53F7086AC92AQ37048205-1415002D-8C16-44BD-8E50-73EE94BD7E6EQ37156639-6D9D32FF-5F4E-4B5A-A382-E147C6265867Q37271477-693267DA-6893-4AB1-9983-6458A025E6DBQ37354128-CAD869AE-F9C6-4CE8-A85E-EA4E1F5DAE71Q37516448-969D61A3-0214-49C4-908B-8F8C3C616C3AQ37954393-FBD3A307-E18A-42ED-80A2-3C403762CDD1Q38064829-D4DB2631-EC92-435E-97EA-59D56D09BEA9Q38066006-A4D61A2A-01C7-48EC-B732-571E0B0626FBQ38126351-CEF8F7F8-9ABC-49AB-9587-29030D9FDAE4Q38190359-5F205B31-467C-45B6-9932-8AC6674416BDQ38388371-FFC31DD8-1400-45FD-8FC4-BF11CD36AFB0Q38867010-931EF222-C62B-4055-9B89-2E01C2D1121DQ39019425-72498014-B0F9-464A-9DF5-99F1CC2A9729Q39165264-5A62B784-1D2C-4A04-B780-4B586E6501E4Q39399152-45771D77-82C2-4FD8-A576-FD1AEE94A30BQ41858308-3116A100-64C7-4B17-AF9A-811DEDCCED64Q42292217-DBC347E4-4CA1-4AC2-BE1A-BDE327C90E4E
P2860
Targeting lymphangiogenesis to prevent tumour metastasis
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Targeting lymphangiogenesis to prevent tumour metastasis
@ast
Targeting lymphangiogenesis to prevent tumour metastasis
@en
type
label
Targeting lymphangiogenesis to prevent tumour metastasis
@ast
Targeting lymphangiogenesis to prevent tumour metastasis
@en
prefLabel
Targeting lymphangiogenesis to prevent tumour metastasis
@ast
Targeting lymphangiogenesis to prevent tumour metastasis
@en
P2093
P2860
P50
P356
P1476
Targeting lymphangiogenesis to prevent tumour metastasis
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603120
P407
P577
2006-05-01T00:00:00Z
2006-05-22T00:00:00Z